Kestra Medical (KMTS) earnings history
Most recent quarter
- Fiscal period
- Q1 2027
- Period end
- Jul 31, 2026
- EPS actual
- −$0.75
- EPS estimate
- −$0.62
- EPS surprise
- −21.77%
- Revenue surprise
- +6.76%
- Revenue
- $31.0M
- Revenue estimate
- $29.0M
- Reported
- Sep 14, 2026
Kestra Medical reported fiscal Q1 2027 results on September 14, 2026. It posted a loss of $0.75 per share, wider than the $0.62 loss expected, a 21.77% miss. Revenue was $31.0 million, 6.76% above the $29.0 million estimate. Compared with Q1 2026, revenue rose about 60% from $19.4 million, while the loss widened from $0.50 per share.
The record is short, with seven quarters starting in Q3 2025, and every quarter was a loss. Revenue has risen in each quarter shown, from $15.1 million to the latest $31.0 million, the table's high. Losses were largest early on, at $1.25 and $2.21 per share in Q3 and Q4 2025, then ranged from $0.50 to $0.75 over the last five quarters. Fiscal 2026, the only complete year here, brought a loss of $2.42 per share on $95.2 million in revenue. Kestra beat the EPS estimate once, in Q1 2026, and missed in the other six quarters.
Kestra reported fiscal Q2 2026 on December 11, 2025, the only Q2 date in the table. That points to around mid-December 2026 for the next report, which will show whether revenue keeps growing and how the loss per share moves.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q1 2027 | Sep 14, 2026 | −$0.62 | −$0.75 | −21.77% | $31.0M | SEC |
| Q4 2026 | Jul 14, 2026 | −$0.59 | −$0.67 | −13.56% | $28.6M | SEC |
| Q3 2026 | Mar 17, 2026 | −$0.60 | −$0.61 | −2.33% | $24.6M | SEC |
| Q2 2026 | Dec 11, 2025 | −$0.59 | −$0.64 | −7.73% | $22.6M | SEC |
| Q1 2026 | Sep 11, 2025 | −$0.61 | −$0.50 | +18.03% | $19.4M | SEC |
| Q4 2025 | Jul 15, 2025 | −$0.53 | −$2.21 | −320.95% | $17.2M | SEC |
| Q3 2025 | Apr 14, 2025 | −$0.60 | −$1.25 | −107.19% | $15.1M | SEC |
Quarterly revenue
Frequently asked questions
When did Kestra Medical (KMTS) last report earnings?
Kestra Medical last reported on Sep 14, 2026, covering fiscal Q1 2027.
Did KMTS beat earnings estimates?
No. Kestra Medical reported EPS of −$0.75 for Q1 2027 against a −$0.62 estimate — a 21.77% miss.
How much revenue did KMTS report last quarter?
Kestra Medical reported $31.0M in revenue for Q1 2027, against a consensus estimate of $29.0M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.